Skip to main content
Ann Arvin, MD, Pediatric Infectious Disease, Stanford, CA

AnnMargaretArvinMD

Pediatric Infectious Disease • Stanford, CA

Professor, Pediatrics - Infectious Diseases, Stanford University Medical Center

Join to view full profile

Are you Dr. Arvin?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
    You already have 49 invites waiting!
  • Read the latest clinical news, personalized to your specialty.

Claim this profile

Not you? Find your profile

  • Office

    300 Pasteur Dr
    G312, Department Of Pediatrics
    Stanford, CA 94305
    Phone+1 659-498-6227
    Fax+1 650-724-4595

Summary

  • Dr. Ann Arvin, MD is a pediatric infectious disease specialist in Stanford, California. She is currently licensed to practice medicine in California. She is affiliated with Stanford Health Care and Lucile Packard Children's Hospital Stanford.

Education & Training

  • University of California (San Francisco)
    University of California (San Francisco)Fellowship, Infectious Disease, 1976 - 1978
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 1974 - 1975
  • University of California (San Francisco)
    University of California (San Francisco)Residency, Pediatrics, 1972 - 1974
  • Perelman School of Medicine at the University of Pennsylvania
    Perelman School of Medicine at the University of PennsylvaniaClass of 1972

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 1973 - 2023
  • American Board of Pediatrics Pediatrics

Awards, Honors, & Recognition

  • Elected Member Institute of Medicine, 2003
  • Fellow (FAAP) American Academy of Pediatrics

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Vaccine Curbs Shingles Cases and Severity
    Vaccine Curbs Shingles Cases and SeverityJune 2nd, 2005
  • Morbidity and Mortality Weekly Report
    Morbidity and Mortality Weekly ReportApril 4th, 2003

Grant Support

  • Varicella-Zoster Virus: T Cell/Skin Tropism &ImmunityNational Institute Of Allergy And Infectious Diseases2010–2012
  • Administrative And Clinical CoreNational Institute Of Allergy And Infectious Diseases2011
  • Varicella-Zoster Virus: Tegument Proteins In PathogenesisNational Institute Of Allergy And Infectious Diseases2009–2011
  • Protective Immunity Against Herpesvirus InfectionsNational Cancer Institute2007–2011
  • Investigation Of Herpes Simplex Virus -1 Neurotropism In SCID DRG XenograftsNational Institute Of Allergy And Infectious Diseases2009–2010
  • Varicella-Zoster Virus: T Cell/Skin Tropisms &ImmunityNational Institute Of Allergy And Infectious Diseases2005–2009
  • Pilot Projects Component (Pilot Proj 2: Guccione)National Institute Of Allergy And Infectious Diseases2008
  • CD8 T Cell Immunity To InfluenzaNational Institute Of Allergy And Infectious Diseases2008
  • Protective Mechanisms Against Pandemic Respiratory VirusNational Institute Of Allergy And Infectious Diseases2003–2008
  • Ontogeny Of Measles Immunity In InfantsNational Institute Of Allergy And Infectious Diseases2007
  • Varicella-Zoster Virus Tegument Proteins In PathogenesisNational Institute Of Allergy And Infectious Diseases2003–2007
  • Ontogeny Of Measles Immunity In InfantsNational Institute Of Allergy And Infectious Diseases1994–2006
  • Antiviral Immune Mechanisms In Early ChildhoodNational Center For Research Resources2004–2005
  • Acquisition Of Human Cytomegalovirus In Preterm, LBWNational Center For Research Resources2004
  • Anti-Viral Immune Mechanisms In Early ChildhoodNational Institute Of Allergy And Infectious Diseases2000–2003
  • Varicella Zoster Virus--T Cell/Skin Tropisms And ImmunitNational Institute Of Allergy And Infectious Diseases1999–2003
  • Evolution Of CD8 T Cell Responses To HCMV In InfantsNational Institute Of Allergy And Infectious Diseases2000–2002
  • Protective Immunity To Varicella Zoster Virus After Bone Marrow TransplantationNational Cancer Institute1997–2002
  • Viral Gastroenteritis--Basis Of Protection And VirulenceNational Institute Of Allergy And Infectious Diseases2001
  • Phenotype Of B Cells Induced By Rotavirus InfectionFogarty International Center2001
  • Treatment Of Herpes Simplex InfectionsNational Center For Research Resources1996–2000
  • Age Related Differences In Cell Mediated Immune Response To VZVNational Center For Research Resources1996–2000
  • Molecular Approaches To Human Viral VaccinesNational Institute Of Allergy And Infectious Diseases1999
  • Immunity &Viral Replication In Children With VaricellaNational Institute Of Allergy And Infectious Diseases1985–1998
  • Regiments Of Oka/Merck Varicella Vaccine In Seronegative Healthy ChildrenNational Center For Research Resources1997
  • Follow UP Of Oka/Merck Varicella Vaccine In Healthy ChildrenNational Center For Research Resources1997
  • 2 Injections Of Oka/Merck Varicella Vaccine In Seronegative PatientsNational Center For Research Resources1997
  • 1 Vs. 2 Injections Of Oka/Merck Varicella Vaccine In Healthy ChildrenNational Center For Research Resources1997
  • Protective Immunity To Varicella-Zoster Virus After Bone Marrow TransplantationNational Cancer Institute1996
  • Primary VZV Infection/ImmunityNational Institute Of Allergy And Infectious Diseases1985–1992
  • Varicella-Zoster Infection/Immunity In Guinea PigsNational Institute Of Allergy And Infectious Diseases1988
  • Herpes Simplex: PREGNANCY, Neonatal Risk, Host DefenseEunice Kennedy Shriver National Institute Of Child Health &Human Development1988
  • Varicella-Zoster Virus--Immunity And Viral ReplicationNational Institute Of Allergy And Infectious Diseases1985–1988
  • Herpes Simplex, Pregnancy Neonatal Risk, Host DefenseEunice Kennedy Shriver National Institute Of Child Health &Human Development1985–1987

Professional Memberships

Dr. Ann Arvin, Dr. Ann Arvin, MD, Dr. A Arvin, Dr. Ann Margaret Arvin